424 P.3d 1261
Wyo.2018Background
- Harborth injured her thoracic/lumbar spine at work (2006) and underwent conservative care and a prior lumbar discectomy; symptoms persisted leading to proposed extensive fusions by a U.S. surgeon.
- Concerned about loss of mobility from fusion, Harborth sought treatment in Germany from Dr. Karsten Ritter‑Lang, who recommended fusions at T12–L1 and artificial disc replacements (M6) at L4–5 and L5–S1; M6 was not FDA‑approved but approved in EU and other countries.
- Harborth traveled to Germany, paid part of the cost herself, and had the surgeries (including adjacent‑level M6 implants); she recovered well and returned to full duty.
- The Wyoming Division denied coverage, classifying the non‑FDA device/procedure as off‑label, experimental/alternative medicine lacking required objective evidence under Division Rules, ch. 10.
- The Medical Commission and the district court upheld the denial, finding (1) implantation of a device that has no FDA approval is not an "off‑label" use under the Division Rule, and (2) Harborth failed to produce objective, reliable documentation of safety/effectiveness to overcome the Division Rule's presumption against alternative medicine.
Issues
| Issue | Harborth's Argument | Division's Argument | Held |
|---|---|---|---|
| Whether the M6 adjacent‑level implants were an "off‑label" use | The M6 use should be treated as off‑label and could be authorized if supported | M6 has no FDA label to deviate from; thus not "off‑label" under Rule ch.10 §19 | Not off‑label; no FDA approval means no label to deviate from |
| Whether substantial evidence supported characterization as "alternative medicine" requiring documentation | Harborth argued the surgery's success, patient testimony, website data, and surgeon statements showed safety/effectiveness | Division argued there was insufficient objective, verifiable literature/studies to meet Rule ch.10 §3 requirements | Substantial evidence supports finding it was "alternative medicine" and Harborth failed to meet documentation burden |
| Whether outcome of Harborth's individual successful surgery was controlling | Harborth argued her positive outcome proves safety/effectiveness | Division argued single success does not substitute for objective population‑level evidence required by the Rules | Court: individual success is not a substitute for required objective documentation |
| Whether the Medical Commission acted arbitrarily or capriciously | Harborth claimed the Commission ignored/discounted admissible evidence and thus was arbitrary | Division contended the Commission considered evidence and reasonably weighed it | Held: decision was not arbitrary or capricious; evidence could reasonably support the outcome |
Key Cases Cited
- Morris v. State ex rel. Dep't of Workforce Servs., Workers' Comp. Div., 403 P.3d 980 (Wyo. 2017) (standard of review of agency decisions and burden of proof reminders)
- Guerrero v. State ex rel. Dep't of Workforce Servs., Workers' Comp. Div., 352 P.3d 262 (Wyo. 2015) (agency review principles)
- Walton v. State ex rel. Wyo. Workers' Safety & Comp. Div., 153 P.3d 932 (Wyo. 2007) (definition of substantial evidence)
- Hildebrant v. State ex rel. Dep't of Workforce Servs., Workers' Safety & Comp. Div., 345 P.3d 875 (Wyo. 2015) (agency given latitude to weigh medical evidence)
- Rodgers v. State ex rel. Wyo. Workers' Safety & Comp. Div., 135 P.3d 568 (Wyo. 2006) (reviewing whole record for substantial evidence)
- Cooper v. Smith & Nephew, Inc., 259 F.3d 194 (4th Cir. 2001) (physician may use cleared device off‑label; court discusses distinction between FDA clearance/approval and physician use)
